Kirk Randal J
SEC-identified person · CIK 1091823 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Precigen, INC. XON | Director · Executive Chairman | filed 2013 - 2026 |
| Aquabounty Technologies, Inc. aqb | Officer | filed 2017 - 2021 |
| Isolagen INC ILEIQ | Officer | filed 2012 - 2019 |
| Theriva Biologics, Inc. TOVX | Officer | filed 2012 - 2019 |
| Ocugen, Inc. OCGN | Officer | filed 2014 - 2019 |
| Ziopharm Oncology INC ZIOP | Director | filed 2011 - 2018 |
| Transgenomic INC TBIOD | Officer | filed 2011 - 2018 |
| Halozyme Therapeutics, INC. Halo | Director | filed 2006 - 2018 |
| Soligenix, INC. SNGX.OB | Officer | filed 2013 - 2017 |
| Targeted Genetics Corp /WA/ TGEN.PK | Officer | filed 2014 - 2016 |
| Oragenics INC orni | Officer | filed 2012 - 2016 |
| Clinical Data INC clda | Director | filed 2006 - 2011 |
| NEW River Pharmaceuticals INC NRPH | Director · Chairman, President and CEO | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.